SAN DIEGO, CA, September 4, 2024 (Newswire.com)
–
The Shareholders Foundation, Inc. announced that September 10, 2024, a deadline is coming up in the lawsuit that was filed for certain investors who purchased shares of CVS Health Corporation (NYSE:CVS). Investors in NYSE: CVS shares should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The Shareholders Foundation, Inc. announced that September 10, 2024, a deadline is coming up in the lawsuit that was filed for certain investors who purchased shares of CVS Health Corporation (NYSE:CVS). Investors who purchased NYSE:CVS shares should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
Shareholders Foundation – mail@shareholdersfoundation.com or +1(858) 779 – 1554
The Shareholders Foundation, Inc. announced that September 10, 2024, a deadline is coming up in the lawsuit that was filed for certain investors who purchased shares of CVS Health Corporation (NYSE:CVS).
mail@shareholdersfoundation.com
Shareholders Foundation – mail@shareholdersfoundation.com or +1(858) 779 – 1554
Investors, who purchased shares in excess of $100,000 of CVS Health Corporation (NYSE:CVS) between May 3, 2023 and April 30, 2024, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
On July 12, 2024, an investor in NYSE: CVS shares filed a lawsuit against CVS Health Corporation over alleged violations of securities laws. The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose tha the forecasts CVS used to determine plan premiums were ineffective at accounting for medical cost trends and health care utilization patterns, that as a result, CVS was likely to incur significant expenses to cover cost increases that were not accounted for in the Company’s forecasts and thus not covered by plan premiums, that accordingly, CVS had overstated the profitability of its Health Care Benefits segment, that contrary to Defendants’ assurances, the revenues generated from the Company’s other primary segments were insufficient to offset the negative financial impact of the increasing expenditures within the Health Care Benefits segment, and that as a result, the Company’s public statements were materially false and misleading at all relevant times.
Those who purchased CVS Health Corporation (NYSE: CVS) shares should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
Contact Information
Michael Daniels
Manager
mail@shareholdersfoundation.com
858-779-1554
SOURCE: Shareholders Foundation, Inc.
Source: Shareholders Foundation, Inc.
